03-14621. New Drug, Antibiotic, and Biological Drug Product Regulations; Accelerated Approval; Technical Amendment  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Final rule; technical amendment.

    SUMMARY:

    The Food and Drug Administration (FDA) is amending the biologics regulations to correct certain errors that were incorporated into the regulations. This action is being taken to improve the accuracy of the regulations.

    DATES:

    This rule is effective June 11, 2003.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Stephen M. Ripley, Center for Biologics Evaluation and Research (HFM-17), Food and Drug Administration, 1401 Rockville Pike, Rockville, MD 20852-1448, 301-827-6210.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    FDA has discovered certain errors that were inadvertently included in the agency's codified regulations for part 601 (21 CFR part 601). In the Federal Register of December 11, 1992 (57 FR 58942), we published a final rule that, among other things, established subpart E of part 601, which encompasses §§ 601.40 through 601.46. Currently, § 601.43(a) refers to § 601.40, instead of the correct § 601.41; § 601.43(b) refers to § 601.40, instead of the correct § 601.42. Accordingly, we are amending § 601.43(a) by replacing the incorrect reference to § 601.40 with a reference to § 601.41, and we are amending § 601.43(b) by replacing the incorrect reference to § 601.40 with a reference to § 601.42. Publication of this document constitutes final action under the Administrative Procedure Act (5 U.S.C. 553). FDA has determined that notice and public comment are unnecessary because this amendment is nonsubstantive.

    Start List of Subjects

    List of Subjects in 21 CFR Part 601

    • Administrative practice and procedure
    • Biologics
    • Confidential business information
    End List of Subjects Start Amendment Part

    Therefore, under the Federal Food, Drug, and Cosmetic Act, and Public Health Service Act, and under authority delegated to the Commissioner of Food and Drugs, 21 CFR part 601 is amended as follows:

    End Amendment Part Start Part Start Printed Page 34797

    PART 601—LICENSING

    End Part Start Amendment Part

    1. The authority citation for 21 CFR part 601 continues to read as follows:

    End Amendment Part Start Authority

    Authority: 15 U.S.C. 1451-1561; 21 U.S.C. 321, 351, 352, 353, 355, 356B, 360, 360c-360f, 360h-360j, 371, 374, 379e, 381; 42 U.S.C. 216, 241, 262, 263, 264; sec. 122, Pub. L. 105-115, 111 Stat. 2322 (21 U.S.C. 355 note).

    End Authority
    [Amended]
    Start Amendment Part

    2. Section 601.43 Withdrawal procedures is amended in the introductory text of paragraph (a) by removing “§§ 601.40 and 640.42” and adding in its place “§ 601.41 or § 601.42”, and in paragraph (b) by removing “§ 601.40 or § 601.41” and adding in its place “§ 601.41 or § 601.42”.

    End Amendment Part Start Signature

    Dated: June 4, 2003.

    Jeffrey Shuren,

    Assistant Commissioner for Policy.

    End Signature End Supplemental Information

    [FR Doc. 03-14621 Filed 6-10-03; 8:45 am]

    BILLING CODE 4160-01-S

Document Information

Effective Date:
6/11/2003
Published:
06/11/2003
Department:
Food and Drug Administration
Entry Type:
Rule
Action:
Final rule; technical amendment.
Document Number:
03-14621
Dates:
This rule is effective June 11, 2003.
Pages:
34796-34797 (2 pages)
Docket Numbers:
Docket No. 91N-0278
PDF File:
03-14621.pdf
CFR: (1)
21 CFR 601.43